Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ablative Solutions bags $77M to complete hypertension device trials

fiercebiotechJanuary 07, 2019

Tag: Ablative Solutions , hypertension device , minimally invasive treatment , denervation technology

PharmaSources Customer Service